3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Colorectal Neoplasms
9
Breast Neoplasms
7
Uterine Cervical Neoplasms
6
Neoplasms
4
Lung Neoplasms
4
Colonic Neoplasms
4
Rectal Neoplasms
2
Prostatic Neoplasms
2
Patient Compliance
2
Papillomavirus Infections
2
Liver Neoplasms
2
Colorectal Cancer Screening
2
Carcinoma, Hepatocellular
2
Tobacco Use
1
Smoking
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma
1
Liver Diseases
1
Hypertension
1
Hepatitis C
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Depression
1
Communication
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
ColoRectal Cancer Screening
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Interventions
Dexamethasone
362
Bortezomib
231
Lenalidomide
200
Cyclophosphamide
174
Melphalan
154
Calcium Dobesilate
107
Peripheral Blood Stem Cell Transplantation
92
fludarabine phosphate
84
Thalidomide
81
Filgrastim
71
carfilzomib
68
pomalidomide
66
Granulocyte Colony-Stimulating Factor
60
Mycophenolic Acid
59
Busulfan
57
daratumumab
54
Whole-Body Irradiation
54
Tacrolimus
51
ixazomib
50
Prednisone
50
Cyclosporine
49
fludarabine
46
Antilymphocyte Serum
35
Etoposide
30
dexamethasone acetate
29
Methotrexate
29
plerixafor
27
Radiotherapy
26
Doxorubicin
26
dexamethasone 21-phosphate
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Multiple Myeloma
×
Patient Navigation
×
Clear all
NCT06063603
2025-09-18
ASCENT
Mayo Clinic
Phase NA
Completed
51 enrolled
8 charts